产品编号：L178540
产品规格：25mg
产品价格：面议
| 标准品编号: | L178540 |
| 名称: | DL-Laudanosine |
| 别名: | (±)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-soquinoline; 1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinoline; (±)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-veratryl-isoquinoline; 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinoline; N-Methyltetrahydropapaverine; NSC 331268; NSC 94267; Veraisoquin |
| CAS号: | 1699-51-0 |
| 分子式: | C₂₁H₂₇NO₄ |
| 外观: | 白色至Light Beige Solid |
| 熔点: | 113-115°C |
| 分子量: | 357.44 |
| 储存: | -20°C Freezer, Under inert atmosphere |
| 溶解度: | Chloroform (Slightly), Ethanol (Slightly, Sonicated) |
| 种类: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; Phenethylamines/Amphetamines; |
| 应用: | DL-Laudanosine is an intermediate in synthesizing (S)-Laudanosine (L178525), a metabolite of the neuromuscular-blocking drugs Atracurium (A794500) and Cisatracurium (C496700) with potentially toxic systemic effects. It crosses the blood-brain barrier and may cause excitement and seizure activity. |
| 危险品: | Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |
| 参考文献 | |
